{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:06:51Z","timestamp":1759342011754},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mechanisms of Ageing and Development"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.mad.2003.12.001","type":"journal-article","created":{"date-parts":[[2003,12,31]],"date-time":"2003-12-31T07:13:11Z","timestamp":1072854791000},"page":"147-148","source":"Crossref","is-referenced-by-count":3,"title":["Post-marketing effectiveness of Prevnar [pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein)] and implications for adult immunization"],"prefix":"10.1016","volume":"125","author":[{"given":"Betsy Abraham-Van","family":"Parijs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J","family":"Malinoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mad.2003.12.001_BIB1","unstructured":"Atkinson, W., Wolfe, C., Humiston, S., Nelson, R. (Eds.), 2000. Pneumococcal disease. In: Epidemiology and Prevention of Vaccine-Preventable Diseases, 6th edition, US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, pp. 249\u2013263."},{"key":"10.1016\/j.mad.2003.12.001_BIB2","unstructured":"Black, S.B., Shinefield, H., Fireman, B., Hansen, J., Ling, S., K.P. Vaccine Study Group, Austrian, R., Siber, G., Hackell, J. Efficacy against pneumonia of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,868 infants and children: expanded data analysis including duration of protection. In: Program and Abstract Book of the 3rd International Symposium on Pneumococci and Pneumococcal Diseases, May 5\u20138, 2002, Anchorage, AK, USA, p. 95."},{"key":"10.1016\/j.mad.2003.12.001_BIB3","unstructured":", Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination levels among persons aged \u226565 years, United States, 1999. Morbid. Mortal. Weekly Report 50 (25), 532\u2013537."},{"key":"10.1016\/j.mad.2003.12.001_BIB4","first-page":"437","article-title":"Essai clinique du vaccin antipneumococcique chez des personnes agees vivant en institution (clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions)","volume":"33","author":"Gaillat","year":"1985","journal-title":"Rev. Epidemiol. Sante Publ."},{"key":"10.1016\/j.mad.2003.12.001_BIB5","doi-asserted-by":"crossref","unstructured":"Klugman, K., Madhi, et al., 2003. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N. Engl. J. Med. 349, 1341\u20131348.","DOI":"10.1056\/NEJMoa035060"},{"key":"10.1016\/j.mad.2003.12.001_BIB6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1086\/318124","article-title":"Community-acquired pneumonia in the elderly","volume":"31","author":"Marrie","year":"2000","journal-title":"CID"},{"key":"10.1016\/j.mad.2003.12.001_BIB7","doi-asserted-by":"crossref","unstructured":"Ortqvist A, Hedlund J, Burman L-A, et al. and the Swedish Pneumoccoccal Vaccination Study Group. Randomised trial of 23-valent pneumcoccal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet 351, 399\u2013403.","DOI":"10.1016\/S0140-6736(97)07358-3"},{"key":"10.1016\/j.mad.2003.12.001_BIB8","unstructured":"Shinefield, H., Black, S.B., K.P. Vaccine Study Group. Impact of the use of pneumococcal conjugate vaccine on invasive pneumococcal disease in older children and adults. In: Presented at the 3rd International Symposium on Pneumococci and Pneumococcal Diseases, May 5\u20138, 2002, Anchorage, AK, USA."},{"key":"10.1016\/j.mad.2003.12.001_BIB9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJM198611203152104","article-title":"Efficacy of pneumococcal vaccine in high-risk patients: results of a veterans administration cooperative study","volume":"315","author":"Simberkoff","year":"1986","journal-title":"NEJM"},{"key":"10.1016\/j.mad.2003.12.001_BIB10","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Declinie in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mad.2003.12.001_BIB11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1086\/322676","article-title":"Rethinking recommendations for use of pneumococcal vaccines in adults","volume":"33","author":"Whitney","year":"2001","journal-title":"CID"}],"container-title":["Mechanisms of Ageing and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637403002501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637403002501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T15:22:25Z","timestamp":1550244145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0047637403002501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0047637403002501"],"URL":"https:\/\/doi.org\/10.1016\/j.mad.2003.12.001","relation":{},"ISSN":["0047-6374"],"issn-type":[{"type":"print","value":"0047-6374"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}